Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
CC transcript
Inv. presentation
|
|
ReShape Weightloss Inc. (RSLS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/04/2019 |
8-K/A
| Financial Statements and Exhibits |
| 12/21/2018 |
8-K/A
| Financial Statements and Exhibits |
| 12/15/2017 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Ernst & Young LLP, independent registered public accounting firm for ReShape Medical, Inc. for the year ended December 31, 2016",
"Consent of Haskell & White LLP, independent registered public accounting firm for ReShape Medical, Inc. for the year ended December 31, 2015",
"Audited financial statements of ReShape Medical, Inc. as of and for the year ended December 31, 2016",
"Audited financial statements of ReShape Medical, Inc. as of and for the year ended December 31, 2015",
"Unaudited financial statements of ReShape Medical, Inc. as of and for the three and nine months ended September 30, 2017",
"Unaudited pro forma financial statements of ReShape Lifesciences Inc" |
|
| 07/10/2017 |
8-K/A
| Form 8-K/A - Current report: [Amend] |
| 02/09/2009 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|
|